Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiora Pharmaceuticals (KPRX) Return on Assets (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Return on Assets for 11 consecutive years, with 0.28% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 40.0% year-over-year to 0.28%, compared with a TTM value of 0.28% through Sep 2025, down 40.0%, and an annual FY2024 reading of 0.14%, changed N/A over the prior year.
  • Return on Assets was 0.28% for Q3 2025 at Kiora Pharmaceuticals, down from 0.09% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.17% in Q1 2024 and bottomed at 1.45% in Q3 2022.
  • Average Return on Assets over 5 years is 0.49%, with a median of 0.36% recorded in 2023.
  • The sharpest move saw Return on Assets tumbled -137bps in 2022, then skyrocketed 85bps in 2024.
  • Year by year, Return on Assets stood at 1.38% in 2021, then decreased by -6bps to 1.45% in 2022, then skyrocketed by 51bps to 0.71% in 2023, then surged by 113bps to 0.09% in 2024, then plummeted by -392bps to 0.28% in 2025.
  • Business Quant data shows Return on Assets for KPRX at 0.28% in Q3 2025, 0.09% in Q4 2024, and 0.12% in Q3 2024.